(NYSE: AORT) Artivion's forecast annual revenue growth rate of 13.69% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Artivion's revenue in 2026 is $422,646,000.On average, 9 Wall Street analysts forecast AORT's revenue for 2026 to be $23,686,995,751, with the lowest AORT revenue forecast at $22,326,861,252, and the highest AORT revenue forecast at $24,622,650,796. On average, 7 Wall Street analysts forecast AORT's revenue for 2027 to be $26,431,899,716, with the lowest AORT revenue forecast at $25,135,721,385, and the highest AORT revenue forecast at $27,619,115,688.
In 2028, AORT is forecast to generate $29,544,433,209 in revenue, with the lowest revenue forecast at $28,385,642,201 and the highest revenue forecast at $30,413,289,590.